Arrowhead nets $250.8mm through FOPO

19:40 EST 6 Dec 2019 | Elsevier Business Intelligence

Arrowhead Pharmaceuticals Inc. netted $250.8mm through the follow-on offering of 4.6mm shares (including the overallotment) a...

Original Article: Arrowhead nets $250.8mm through FOPO


More From BioPortfolio on "Arrowhead nets $250.8mm through FOPO"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...